DACARBAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dacarbazine, and when can generic versions of Dacarbazine launch?
Dacarbazine is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Hikma, Hospira, and Meitheal. and is included in six NDAs.
The generic ingredient in DACARBAZINE is dacarbazine. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dacarbazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dacarbazine
A generic version of DACARBAZINE was approved as dacarbazine by MEITHEAL on August 27th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DACARBAZINE?
- What are the global sales for DACARBAZINE?
- What is Average Wholesale Price for DACARBAZINE?
Summary for DACARBAZINE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 239 |
| Patent Applications: | 5,281 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DACARBAZINE |
| DailyMed Link: | DACARBAZINE at DailyMed |
Recent Clinical Trials for DACARBAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Diwakar Davar | Phase 2 |
| IDEAYA Biosciences | Phase 2/Phase 3 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 3 |
Pharmacology for DACARBAZINE
| Drug Class | Alkylating Drug |
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for DACARBAZINE
Anatomical Therapeutic Chemical (ATC) Classes for DACARBAZINE
US Patents and Regulatory Information for DACARBAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 070962-001 | Aug 28, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075940-001 | Oct 18, 2001 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075371-002 | Aug 27, 1999 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Meitheal | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075259-002 | Aug 27, 1998 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abraxis Pharm | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 070990-001 | Aug 28, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075371-001 | Aug 27, 1999 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075812-002 | Oct 31, 2002 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
